Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jul 23;18(15):7819.
doi: 10.3390/ijerph18157819.

Therapeutic Management of Rare Primary Ovarian Neoplasms: Carcinosarcoma, Leiomyosarcoma, Melanoma and Carcinoid

Mateusz Kozłowski  1 , Katarzyna Nowak  1 , Agnieszka Kordek  2 , Aneta Cymbaluk-Płoska  1
Affiliations
Review

Therapeutic Management of Rare Primary Ovarian Neoplasms: Carcinosarcoma, Leiomyosarcoma, Melanoma and Carcinoid

Mateusz Kozłowski et al. Int J Environ Res Public Health. .

Abstract

Carcinosarcoma, leiomyosarcoma, melanoma and carcinoid as primary tumors in the ovary are extremely rare. In this paper, the authors reviewed the literature from 2010 to 2021, based on specific criteria, to analyze the treatment of these rare ovarian neoplasms. We also aimed to verify whether modern therapies have been found in recent years. For this article, 80 papers were finally selected. The vast majority of the articles were clinical case reports. Despite single mentions of new potential pharmacological treatments, surgery (radical or fertility-sparing) is definitely the mainstay of treatment. There are currently no treatment guidelines for these tumors. A review of the literature has revealed the use of various adjuvant treatments. We, therefore, believe that a more detailed understanding of the biology of these tumors is necessary in order to find new target points for treatment. We would like to emphasize the importance of creating an international database of rare ovarian tumors which would make it possible to gather data from various oncological centers and enable further research into these neoplasms.

Keywords: adjuvant treatment; cancer care; carcinoid of the ovary; carcinosarcoma of the ovary; leiomyosarcoma of the ovary; ovarian malignant melanoma; surgery.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Diagram of current treatment and potential future treatment options in rare primary ovarian neoplasms.
See this image and copyright information in PMC

References

    1. Rauh-Hain J.A., Growdon W.B., Rodriguez N., Goodman A., Boruta D., Schorge J.O., Horowitz N.S., Del Carmen M.G. Carcinosarcoma of the ovary: A case–control study. Gynecol. Oncol. 2011;121:477–481. doi: 10.1016/j.ygyno.2011.02.023. - DOI - PubMed
    1. George E.M., Herzog T.J., Neugut A.I., Lu Y.-S., Burke W.M., Lewin S.N., Hershman D.L., Wright J.D. Carcinosarcoma of the ovary: Natural history, patterns of treatment, and outcome. Gynecol. Oncol. 2013;131:42–45. doi: 10.1016/j.ygyno.2013.06.034. - DOI - PMC - PubMed
    1. Patnayak R., Jena A., Prakash J., Sundaram R., Vijaylaxmi B., Lakhmi A. Primary carcinosarcoma of ovary an unusual tumor case report with review of literature. J. Basic Clin. Reprod. Sci. 2015;4:39. doi: 10.4103/2278-960X.153526. - DOI
    1. Dasgupta S., Bose D., Bhattacharyya N., Biswas P. Carcinosarcoma of ovary with its various immunohistochemical expression: Report of a rare case. J. Cancer Res. Ther. 2015;11:1022. doi: 10.4103/0973-1482.147390. - DOI - PubMed
    1. Kojima G., Terada K.Y., Miki N., Miki K. Non-Islet Cell Tumor Hypoglycemia Associated With Recurrent Carcinosarcoma of the Ovary. Endocr. Pract. 2013;19:83–87. doi: 10.4158/EP13002.CR. - DOI - PubMed